Pulse Biosciences, Inc. 8-K Report: Key Insights & Filing Details

Here are the key insights extracted from the provided section of the financial report:

1. Entity Information:

• Company Name: Pulse Biosciences, Inc.
• CIK Number: 0001625101
• Central Index Key (SEC): 001-37744
• EIN: 46-5696597
• Address: 601 Brickell Key Drive, Suite 1080, Miami, FL 33131
• Phone Number: 510-906-4600

2. Filing Details:

• Filing Type: 8-K (a form used to report major events that shareholders should know about)
• Filing Date: December 23, 2024

3. Stock Information:

• Common Stock Ticker Symbol: PLSE
• Exchange: NASDAQ

4. Reporting Period:

• Start Date: December 23, 2024
• End Date: December 23, 2024

5. XBRL Information:

• The report is structured in XBRL format, indicating it is intended for digital filing and analysis.

This information provides a snapshot of Pulse Biosciences, Inc.'s SEC filing, which is crucial for investors, analysts, and stakeholders to assess the company's current status and any significant events reported on that date.